Status:
COMPLETED
Epidemiological Study In Hypertensive Patients: Assessment Of Risk Factors Prevalence And Of Patients' Management
Lead Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Conditions:
Hypertension
Eligibility:
All Genders
18-80 years
Brief Summary
To assess the pattern of hypertension in the population in terms of presence of additional risk factors (ARF) and cardiovascular risk stratification.
Detailed Description
routine physician visits
Eligibility Criteria
Inclusion
- Age 18 to 80 years old
- Patients with hypertension: newly diagnosed and /or already diagnosed and treated , whether at goal or not for the blood pressure level;
- Patients with no history of CHD/CVD
Exclusion
- None
Key Trial Info
Start Date :
June 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2009
Estimated Enrollment :
899 Patients enrolled
Trial Details
Trial ID
NCT00709787
Start Date
June 1 2008
End Date
February 1 2009
Last Update
January 27 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Varaždin, Croatia, 42000
2
Pfizer Investigational Site
Prague, Czechia, 140 00